Targeted Therapies in Oncology
December 2, 2020
Volume: 9
Issue: 18
December 1 2020
Volume: 9
Issue: 17
November 2 2020
Volume: 9
Issue: 16
November 1 2020
Volume: 9
Issue: 15
October 2 2020
Volume: 9
Issue: 14
October 1, 2020
Volume: 9
Issue: 13
September 1 2020
Volume: 9
August 1 2020
Volume: 9
Issue: 1
July 1 2020
Volume: 9
Issue: 9
July 2 2020
Volume: 9
Issue: 10
June 1 2020
Volume: 9
Issue: 8
May 1 2020
Volume: 9
Issue: 5
April 2 2020
Volume: 9
Issue: 6
April 1 2020
Volume: 9
Issue: 5
March 1 2020
Volume: 9
Issue: 4
February 2 2020
Volume: 9
Issue: 3
February 1 2020
Volume: 9
Issue: 2
January 2020
Volume: 9
Issue: 1
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Approves Subcutaneous Amivantamab for EGFR-Mutated NSCLC Indications
2
Long-Term ECHO Data Support Concurrent Acalabrutinib/BR in MCL
3
Pelareorep Offers Promise in Second-Line KRAS-Mutant Metastatic CRC
4
Phase 3 Data Highlight Orca-T’s Clinical Benefits in Heme Malignancies
5